2024-08-08 Chengdu Purevalley Medical Technology New Construction Project of Radionuclide Temporary Storage Workplace Environmental Impact Assessment Report Sheet Full Public Notice

2024-07-22 Grand Pharma Completed the Acquisition of Tianjin Tanabe and Baiji Pharmaceutical

2024-06-28 Sirtex Medical Partners with MediTrust Health to Explore Innovative Payment Models for Liver Tumor Patients in China

2024-06-26 Grand Pharma at the Respiratory Event: Sharing Cutting-Edge Theories and Clinical Applications in Respiratory Medicine

2024-06-26 Grand Pharma Appears at the 88th PHARMCHINA

2024-06-11 The Phase I Clinical Study Conducted in China of the Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment

2024-05-31 Grand Pharma 2024 Investor Open Day

2024-04-24 Employer Presentations at Wuhan University and Huazhong University of Science and Technology

2024-03-28 Grand Pharma Introduces a Global Innovative Product for the Treatment of Demodex Blepharitis and Meibomian Gland Disease with Demodex Mites

2024-03-25 The Global Innovative RDC Drug of Grand Pharma ITM-11 Is Approved to Conduct Phase III Clinical Study in China

2024-03-22 Grand Pharma Announced Annual Results for the Year Ended 31 December 2023

2024-03-11 Grand Pharma’s Two Global Innovative Ophthalmic Products Have Achieved Significant Progress. The NDA of GPN00833 Has Been Approved by the FDA, GPN00884 Has Been Approved to Conduct Phase I Clinical Study in China